|Articles|August 5, 2014
Venn Life Sciences Acquires French CRO
Venn Life Sciences announced the acquisition of Cardinal Systems SAS
Advertisement
Venn Life Sciences, a CRO based in Europe, announced the acquisition of Cardinal Systems SAS, a France based CRO specializing in data management and randomization systems. The acquisition extends Venn’s service offering into those two areas, and strengthens the company’s position as a full-service European CRO.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
2
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
3
ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma
4
ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap
5